Smith & Nephew has received Japanese regulatory approval for its Oxinium oxidized zirconium technology.
Subscribe to our email newsletter
This approval marks the first time Smith & Nephew’s technology will be available in the world’s second largest orthopaedic market. The Genesis II knee system will be the first implant system available in Japan with Oxinium.
Smith & Nephew is said to be the only orthopaedic company to offer an award winning joint replacement material. Oxinium is a proprietary transformed metal alloy with a ceramic bearing surface that provides low friction and wear resistance combined with the strength of a metal implant.
Joseph DeVivo, president of Smith & Nephew Orthopedic Reconstruction, said: “Oxinium material has proven to be a superior metal in implants, and our technology has given patients the significant benefit of greater durability from their implants.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.